Company Description
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally.
The company operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing.
It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.
It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, and regulatory review.
In addition, the company sells beta-alanine ingredients under the CarnoSyn, TriBsynm, CarnoSyn 4X, and SR CarnoSyn names.
It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders.
The company’s private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores.
Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
| Country | United States |
| Founded | 1980 |
| IPO Date | Mar 13, 1987 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 301 |
| CEO | Mark LeDoux |
Contact Details
Address: 1535 Faraday Avenue Carlsbad, California 92008 United States | |
| Phone | 760-736-7700 |
| Website | nai-online.com |
Stock Details
| Ticker Symbol | NAII |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000787253 |
| CUSIP Number | 638842302 |
| ISIN Number | US6388423021 |
| Employer ID | 84-1007839 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Mark A. LeDoux J.D. | Chairman of the Board and Chief Executive Officer |
| Kenneth E. Wolf CPA | President, Chief Operating Officer, Secretary, Principal Financial and Principal Accounting Officer |
| Shane Conti | Vice President of Global Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 28, 2026 | 10-K | Annual Report |
| May 21, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 19, 2026 | 10-Q | Quarterly Report |
| May 18, 2026 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| May 1, 2026 | 8-K | Current Report |
| Mar 20, 2026 | 8-K | Current Report |
| Feb 13, 2026 | 10-Q | Quarterly Report |
| Jan 21, 2026 | SCHEDULE 13G/A | Filing |
| Dec 17, 2025 | 8-K | Current Report |
| Dec 12, 2025 | 8-K | Current Report |